CHEVON VANEPPS: Open Payments
NPI 1790191120 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 28 payments from 10 companies in 2025. Trend: 2023 $507 · 2024 $539 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $187 |
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| GlaxoSmithKline, LLC. | 3 | $86 |
| Phathom Pharmaceuticals, Inc. | 1 | $60 |
| Exact Sciences Corporation | 2 | $41 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, VOQUEZNA, Ozempic, AIRSUPRA, Wegovy, FARXIGA, Rybelsus, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
